Quarterly Consolidated Statement Of Cash Flows

Human Metabolome Technologies, Inc. - Filing #7308027

Concept 2023-07-01 to
2024-06-30
As at
2024-06-30
2023-07-01 to
2024-06-30
As at
2023-06-30
2022-07-01 to
2023-06-30
2022-07-01 to
2023-06-30
As at
2022-06-30
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
261,903,000 JPY
250,822,000 JPY
223,830,000 JPY
237,002,000 JPY
Depreciation
86,315,000 JPY
80,386,000 JPY
Impairment losses
624,000 JPY
JPY
Increase (decrease) in allowance for doubtful accounts
4,224,000 JPY
JPY
Interest and dividend income
-14,000 JPY
-14,000 JPY
Interest expenses
2,095,000 JPY
2,265,000 JPY
Decrease (increase) in trade receivables
-96,096,000 JPY
29,392,000 JPY
Decrease (increase) in inventories
-10,774,000 JPY
17,182,000 JPY
Increase (decrease) in trade payables
15,038,000 JPY
-123,000 JPY
Other, net
6,981,000 JPY
-904,000 JPY
Subtotal
236,702,000 JPY
306,176,000 JPY
Interest and dividends received
14,000 JPY
14,000 JPY
Interest paid
-2,095,000 JPY
-2,265,000 JPY
Net cash provided by (used in) operating activities
236,795,000 JPY
284,962,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-32,479,000 JPY
-98,786,000 JPY
Net cash provided by (used in) investing activities
-32,441,000 JPY
-116,755,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-23,000 JPY
Dividends paid
-58,696,000 JPY
JPY
Net cash provided by (used in) financing activities
-73,153,000 JPY
-13,754,000 JPY
Effect of exchange rate change on cash and cash equivalents
516,000 JPY
-2,407,000 JPY
Net increase (decrease) in cash and cash equivalents
131,717,000 JPY
152,045,000 JPY
Cash and cash equivalents
1,788,506,000 JPY
1,656,789,000 JPY
1,504,744,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.